In the midst of the 2020 coronavirus pandemic, healthcare leaders have been – and will continue to be – inundated with grand proclamations: things will never be the same; you must prepare for “the new normal;” adapt or perish.
While framed as platitudes, there can be no doubt that most players in the healthcare sector have had to quickly adapt to new and often painful economic and public health realities.
But some health insurers and managed care organizations are not currently experiencing the same level of financial distress as other sector participants. In a new article, A&M’s Ron Vance discusses how the coronavirus will present opportunities for such organizations.
Click here to read our article.
OPTIONS TO SUPPORT VIABILITY FOR AUSTRALIA’S PRIVATE HOSPITAL SYSTEM
July 3, 2025
The Australian healthcare system has long been recognised as a global leader, balancing public, and private care to deliver exceptional outcomes for patients.This paper outlines a pathway to safeguard the future of Australia’s private hospital network
A&M continues to grow Private Equity Performance Improvement business in Europe
June 26, 2025
David Pérez joins to expand the firm’s commercial due diligence capabilities, deepen healthcare sector expertise and bolster the Nordic footprint.
Impending Medicaid Funding Reductions — Strategic Implications for Health Plans
June 11, 2025
In a recent article, A&M Healthcare Industry Group experts explore key policy changes, market dynamics, stakeholder implications and strategic actions for navigating the evolving landscape surrounding the Affordable Care Act marketplace.
Disruption in the ACA Market – Implications and Strategic Responses
June 11, 2025
In a recent article, A&M Healthcare Industry Group experts explore key policy changes, market dynamics, stakeholder implications and strategic actions for navigating the evolving landscape surrounding the Affordable Care Act marketplace.
